Marker Therapeutics, Inc.
MRKR· Nasdaq
MRKRMarker Therapeutics, Inc.
Filed Nov 21, 2011 · 10-Q · 52 days after period end · 0001424884-11-000163
| Metric | Q3 2011 | Q3 2010 |
|---|---|---|
| Net Income | -$844.28K | -$1.01M |
| EPS Diluted | -$0.02 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marker Therapeutics, Inc. · CIK 1094038 · Engraved from SEC EDGAR
ended Sep 30, 2011 · filed Nov 21, 2011 · 52 d after period end
